Skip to main content

Table 1 Characterization of the cohort of 193 prostate cancer samples

From: Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer

Characteristics n (%)
Age (years)  
< 50 11 (5.69)
50 - 70 160 (82.9)
>70 21 (11.4)
Preoperative PSA (ng/ml)  
< 10 114 (60.6)
10 ≥ PSA < 20 50 (26.5)
≥ 20 24 (12.9)
TNM stage (pathologic)  
II 95 (49.2)
III 86 (44.6)
IV 8 (6.23)
Gleason score  
6 (3 + 3) 102 (52.8)
7 (3 + 4) 46 (23.8)
7 (4 + 3) 19 (9.8)
8 - 10 26 (13.5)
Angiolymphatic invasion  
Presence 44 (23.2)
Absence 146 (76.9)
Extraprostatic extension  
Presence 41 (21.7)
Absence 148 (78.3)
Positive margin  
Presence 68 (21.6)
Absence 122 (78.4)
Seminal vesicle invasion  
Presence 22 (11.6)
Absence 168 (88.4)
Positive lymph node  
Presence 10 (5.44)
Absence 174 (94.6)
Biochemical recurrence  
Presence 115 (60.5)
Absence 75 (39.5)